Immunological alterations in patients with treated Whipple's disease.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000032:analysis; D001345:Autoradiography; D001706:Biopsy; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007413:Intestinal Mucosa / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D012882:Skin Tests; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D008061:Whipple Disease / Q000188:drug therapy / Q000276:immunology*
D000900:Anti-Bacterial Agents; D000974:Antibodies, Antinuclear; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014316:Tritium; D003165:Complement System Proteins; D013936:Thymidine